Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer

Journal of Urology

Volumn 157, Issue 4, 1997, Pages 1254-1258

  Neulander, Endre ^a   Kaneti, Jacob ^a   Chaimovitz, Cidio ^a   Sion Vardy, Netta ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

bladder neoplasms; carcinoma; DNA; flow cytometry; ploidies; transitional cell

Indexed keywords

BCG VACCINE; DNA; THIOTEPA;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTRAVESICAL DRUG ADMINISTRATION; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0030998521     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64941-3     Document Type: Article

References (29)

1. Blomjous, C. E., Schipper, N. W., Baak, J. P., van Galen, E. M., de Voogt, H. J. and Meyer, C. J.: Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J. Clin. Path., 41: 21, 1988.
2. Al-Abadi, H. and Nagel, R.: Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. J. Urol., 151: 37, 1994.
3. Tribukait, B., Gustafson, H. and Esposti, P. L.: The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Brit. J. Urol., 54: 130, 1982.
4. Gustafson, H. and Tribukait, B.: Characterization of bladder carcinomas by flow DNA analysis. Eur. Urol., 11: 410, 1985.
5. Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A. and Musgrove, E. A.: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem., 31: 1333, 1983.
6. Norming, U., Tribukait, B., Gustafson, H., Nyman, C. R., Wang, N. N. and Wijkstrom, H.: DNA profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. J. Urol., 147: 11, 1992.
7. Joensuu, H., Klemi, P. and Eerola, E.: DNA aneuploidy in follicular adenomas of the thyroid gland. Amer. J. Path., 124: 373, 1986.
8. Fallenius, A. G., Auer, G. U. and Carstensen, J. M.: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer, 62: 331, 1988.
9. Fallenius, A. G., Franzén, S. A. and Auer, G. U.: Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases. Cancer, 62: 521, 1988.
10. Erhardt, K., Auer, G., Björkholm, E., Forsslund, G., Moberger, B., Sifverswärd, C., Wicksell, G. and Zetterberg, A.: Prognostic significance of nuclear DNA content in serous ovarian tumors. Cancer Res., 44: 2198, 1984.
11. Zetterberg, A. and Esposti, P. L.: Prognostic significance of nuclear DNA levels in prostatic carcinoma. Scand. J. Urol. Nephrol., suppl., 55: 53, 1980.
12. Hedley, D. W.: Flow cytometry using paraffin-embedded tissue: five years on. Cytometry, 10: 229, 1989.
13. deVere, White, R. W. and Deitch, A. D.: The role of flow cytometry in urologic disease. Sem. Urol., 3: 132, 1985.
14. Lipponen, P. K., Eskelinen, M. J. and Nordling, S.: Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: relation to tumor histology. Eur. Urol., 20: 311, 1991.
15. Gustafson, H., Tribukait, B. and Esposti, P. L.: The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand. J. Urol. Nephrol., 16: 141, 1982.
16. Lipponen, P. K., Eskelinen, M. J., Jauhiainen, K., Terbo, R. and Nordling, S.: Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours. Brit. J. Urol., 72: 451, 1993.
17. Norming, U.: DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder. Sem. Urol., 11: 154, 1993.
18. Stephenson, R. A.: Flow cytometry in genitourinary malignancies using paraffin-embedded material. Sem. Urol., 6: 46, 1988.
19. Jacobsen, A. B., Fossa, S. D., Thorud, E., Lunde, S., Melvik, J. E. and Pettersen, E. O.: DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material. APMIS, 96: 25, 1988.
20. Kirkhus, B., Clausen, O. P., Fjordvang, H., Iversen, O. H., Reitan, J. B., Vaage, S. and Helander, K.: Characterization of bladder tumours by multiparameter flow cytometry with special reference to grade II tumors. APMIS, 96: 783, 1988.
21. Gaetano, C., Pollack, A. and Block, N.: Flow cytometric analysis of DNA and nuclear protein in paraffin embedded tissue. Cytometry, 14: 205, 1993.
22. Heiden, T., Wang, N. and Tribukait, B.: An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry, 12: 614, 1991.
23. Joensuu, H. and Kallioniemi, O. P.: Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry, 10: 711, 1989.
24. Joensuu, H., Alanen, K. A., Klemi, P. J. and Aine, R.: Evidence for false aneuploid peaks in flow cytometric analysis of paraffin-embedded tissue. Cytometry, 11: 431, 1990.
25. Bretton, P. R., Herr, H. W., Kimmel, M., Fair, W. R., Whitmore, W. F., Jr. and Melamed, M. R.: Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with Bacillus Calmette-Guerin. J. Urol., 141: 1332, 1989.
26. Murphy, W. M., Chandler, R. W. and Trafford, R. M.: Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas. J. Urol., 135: 694, 1986.
27. Frankfurt, O. S. and Huben, R. P.: Clinical applications of DNA flow cytometry for bladder tumors. Urology, suppl., 3: 29, 1984.
28. Devonec, M., Darzynkiewicz, Z., Kostyrka-Claps, M. L., Collste, L., Whitmore, W. F., Jr. and Melamed, M. R.: Flow cytometry of low stage bladder tumors: correlation with cytologic and cystoscopic diagnosis. Cancer, 49: 109, 1982.
29. Witjes, W. P. J., Oosterhof, G. O. N. and Debruyne, F. M. J.: Update on the Dutch cooperative trial: mitomycin versus bacillus Calmette-Guerin-tice versus bacillus Calmette-Guerin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Sem. Urol. Oncol., 14: 10, 1996.